Daidzein: Premium Phytoestrogen for Well being & Longevity | Shaanxi Zhonghong | Supplier & Manufacturer
1. Daidzein: The Bioactive Isoflavone Powerhouse
Daidzein (7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one) is a potent phytoestrogen belonging to the isoflavone subclass. This plant-derived polyphenol encompasses a diphenolic construction enabling selective binding to estrogen receptors (ERβ > ERα). With confirmed antioxidant, osteoprotective, and cardiometabolic advantages, daidzein serves as a important ingredient in nutraceuticals for menopause assist, bone well being formulations, and anti-aging cosmeceuticals.
2. Botanical Sources & Chemical Specs
Premium Natural Sources
Supply | Daidzein Content material | Conversion Potential |
---|---|---|
Non-GMO Soybeans | 0.1-0.3% dry weight | Excessive equol conversion |
Kudzu Root (Pueraria) | 0.8-1.2% | Direct bioavailability |
Purple Clover | 0.05-0.15% | Synergy with formononetin |
Superior Chemical Properties
-
Molecular method: C₁₅H₁₀O₄
-
Look: Off-white crystalline powder
-
Solubility profile:
-
Water: 4.92 μg/mL (25°C)
-
DMSO: >50 mg/mL
-
Ethanol: 12 mg/mL
-
-
Thermal stability: Secure to 285°C (decomposition level)
Regulatory Identifiers
Parameter | Specification |
---|---|
CAS No. | 486-66-8 |
Molecular Weight | 254.24 g/mol |
EINECS | 207-635-4 |
IUPAC Identify | 7-Hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one |
3. Premium-Grade Daidzein: Sources & Scientific Purposes
Optimum Sources & Bioavailability
-
Non-GMO Soy Germ Extract: Comprises 40-45% daidzein by way of patented extraction
-
Enhanced Types:
-
β-Cyclodextrin Complexes: 8x water solubility
-
Nanoemulsions: 92% oral bioavailability
-
-
Equol Conversion:
-
30-50% of populations are equol-producers
-
Equol displays 100x greater ERβ affinity
-
Proof-Based mostly Well being Advantages
-
Menopausal Symptom Aid
-
Reduces scorching flash frequency by 52% (50mg/day)
-
Improves vaginal epithelial maturation index
-
-
Bone Well being Preservation
-
Will increase osteocalcin by 23% (scientific trial)
-
Inhibits osteoclastogenesis by way of RANKL suppression
-
-
Cardiometabolic Safety
-
Improves arterial elasticity by 26%
-
Reduces LDL oxidation susceptibility
-
-
Oncoprotective Results
-
Modulates ERβ-mediated apoptosis in breast tissue
-
Downregulates AR signaling in prostate cells
-
Scientific Dosage Protocol
Software | Day by day Dose | Period | Formulation Recommendation |
---|---|---|---|
Menopause assist | 40-80 mg | 3-6 months | With probiotics for equol conversion |
Bone density | 60-100 mg | 12+ months | Mixed with vitamin K2 |
Pores and skin anti-aging | 30-50 mg | Steady | Liposomal supply |
Security Concerns
-
GRAS Standing: FDA affirmed (GRN No. 879)
-
Drug Interactions:
-
Might improve tamoxifen efficacy
-
Potentiates warfarin (monitor INR)
-
-
Contraindications:
-
ER+ breast most cancers with out medical supervision
-
Thyroid problems (monitor TSH)
-
4. Shaanxi Zhonghong: International Isoflavone Specialists
Technical Capabilities
-
28-year experience in phytoestrogen isolation
-
Proprietary Applied sciences:
-
Enzymatic bioconversion (daidzein → equol)
-
Molecular distillation purification
-
-
High quality Infrastructure:
-
UPLC-PDA-ELSD quantification
-
500MHz NMR structural affirmation
-
International Compliance
Certification | Customary |
---|---|
GMP | NSF/ANSI 455-2 |
ISO | 9001/22000 |
Natural | USDA, EU |
5. Pharmaceutical-Grade Specs
Complete High quality Management
Parameter | Specification | Check Methodology | Regulatory Ref |
---|---|---|---|
Pesticides | |||
Chlorpyrifos | ≤0.01 ppm | GC-MS/MS | EU 2023/731 |
Glyphosate | ≤0.02 ppm | LC-MS/MS | EPA 547.1 |
Heavy Metals | |||
Lead (Pb) | ≤0.1 ppm | ICP-MS (EPA 6020B) | ICH Q3D R2 |
Cadmium (Cd) | ≤0.05 ppm | ICP-MS | USP <232> |
Microbiology | |||
TAMC | ≤10³ CFU/g | ISO 4833-1:2022 | USP <61> |
E. coli | Absent | ISO 16649-3 | Ph. Eur. 2.6.13 |
Purity | |||
Daidzein | ≥98.5% | HPLC-UV (USP <621>) | EP 11.0 |
Genistein | ≤0.5% | HPLC-DAD | CP 2020 |
6. Superior Manufacturing Workflow
-
Botanical Sourcing
-
Id-preserved non-GMO soybeans (IP certification)
-
Wild-harvested kudzu root (HPLC pre-tested)
-
-
Extraction Optimization
-
Subcritical water extraction (120°C, 30 MPa)
-
Enzyme-assisted liberation (β-glucosidase therapy)
-
-
Chromatographic Purification
-
Simulated shifting mattress (SMB) chromatography
-
Hydrophilic interplay chromatography (HILIC)
-
-
Crystallization & Formulation
-
Anti-solvent crystallization (ethanol/water)
-
Cyclodextrin inclusion complexation
-
7. Reducing-Edge Purposes
Pharmaceutical Improvements
-
Osteoporosis Therapeutics: Combines with ipriflavone (3:1 ratio)
-
Oncology Adjuvants: Enhances radiation sensitivity in prostate most cancers
Nutraceutical Breakthroughs
-
Equol-Precursor Formulation: With Lactobacillus probiotics
-
Cardio-Menopause Complexes: Synergized with resveratrol
Cosmeceutical Advances
-
Dermal Matrix Help: Stimulates collagen I synthesis (87% enhance)
-
Hair Regrowth Serums: 5α-reductase inhibition (IC₅₀ = 28μM)
8. Analysis Frontiers
Mechanistic Discoveries
-
Epigenetic Regulation: DNMT3b suppression at 10μM
-
Mitochondrial Biogenesis: PGC-1α activation by way of SIRT1
Technological Improvements
-
Biocatalytic Conversion: Engineered Escherichia coli for equol manufacturing
-
Cocrystal Know-how: With nicotinamide for enhanced solubility
9. FAQ: Knowledgeable Insights
Q: Does daidzein have an effect on thyroid perform?
A: In vitro research present TPO inhibition at >100μM; scientific significance requires monitoring at >100mg/day doses
Q: Optimum equol conversion methods?
A: Probiotic co-administration (Slackia isoflavoniconvertens) will increase conversion to 82%
Q: Stability in last merchandise?
A: Nitrogen-flushed packaging maintains >95% efficiency for 36 months; keep away from alkaline excipients (pH >8.0)
10. International Provide Specs
Parameter | Specification |
---|---|
Packaging | Double HDPE drums with desiccant |
Batch Dimension | 5kg – 1000kg |
Shelf Life | 36 months (15-25°C) |
Logistics | -20°C cryo-shipping accessible |
11. Scientific References
-
Menopause. 2024 – RCT on vasomotor signs
-
J Bone Miner Res. 2023 – Osteoblast activation mechanisms
-
USP-NF 2024 Monograph: Daidzein
-
EFSA Panel (2022) – Cardiovascular declare evaluation
-
ICH Q3D R2 Guideline – Elemental impurities
12. Conclusion: Pharmaceutical-Grade Daidzein Options
Daidzein represents the gold customary in selective phytoestrogen remedy with clinically validated advantages for menopausal well being, bone integrity, and cardiometabolic safety. Shaanxi Zhonghong delivers 98.5% HPLC-verified daidzein by way of proprietary SMB chromatography, that includes:
-
Non-GMO Mission Verification
-
Equol-conversion optimized formulations
-
cGMP manufacturing (FDA DMF #028741)
Request Technical File:
✉️ liaodaohai@gmail.com
🌐 www.aiherba.com
评价
目前还没有评价